RecruitingNot ApplicableNCT06463470

Cognitive Behavioural Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR)

Cognitive Behavioural Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR): An Evaluation of the Feasibility, Acceptability and Effectiveness in Individuals Aged 12 to 25 Years


Sponsor

Orygen

Enrollment

20 participants

Start Date

Jun 27, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

CBT-AR describes an adaption of cognitive behavioural therapy for use with individuals diagnosed with Avoidant/Restrictive Food Intake Disorder (ARFID). The purpose of this evaluation is to determine the feasibility, acceptability and effectiveness of this treatment. It is hypothesised that this treatment will be feasible and acceptable to clinicians, carers and patients and will be effective in reducing symptoms of ARFID for patients.


Eligibility

Min Age: 12 YearsMax Age: 25 Years

Inclusion Criteria3

  • Current primary diagnosis of ARFID according to DSM-5 criteria as determined by the treating team (the eating disorders Orygen Specialist Program
  • Presenting for treatment in the eating disorders Orygen Specialist Program
  • If \<16yo, or \>16 but underweight (BMI \<18.5) and living with their parents/guardian, a parent/guardian should be involved in the treatment.

Exclusion Criteria2

  • Current tube feeding
  • Inappropriateness for CBT-AR as determined by the clinicians (e.g. if there are more urgent issues to first manage such as high suicidal ideation, if participants do not have adequate comprehension capability, etc)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCognitive Behavioural Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR)

CBT-AR describes an adaption of cognitive behavioural therapy for use with individuals diagnosed with Avoidant/Restrictive Food Intake Disorder (ARFID).


Locations(2)

Orygen Youth Health - Sunshine - Sunshine

Melbourne, Victoria, Australia

Orygen Youth Health - Parkville - Parkville

Melbourne, Victoria, Australia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06463470


Related Trials